Uppsala University Hospital Selects Proscia To Deliver Full-Scale Digital Pathology Adoption

By AIT News Desk On Feb 3, 2022

Multi-year agreement will power 100% digitization of Uppsala’s clinical workflow and future AI integrations

Proscia, the leader in digital and computational pathology solutions, and Uppsala University Hospital, Sweden’s oldest university hospital announced a multi-year agreement to fully digitize the region’s pathology workflows. The division of Laboratory Medicine at Uppsala University Hospital has selected Proscia’s Concentriq Dx® digital pathology solution for full-scale digitization and future deployment of AI applications in routine operations at scale, empowering the region’s pathologists to drive increased quality and productivity gains and unlock hidden insights to better inform patient care.

The widespread adoption of digital pathology is enabling laboratories to push past the limitations of traditional pathology practices. As laboratories adopt digital pathology, they must leverage a complex ecosystem of hardware and software solutions that each play a key role in the pathologist’s workflow. These laboratories are now recognizing that practicing digital pathology at scale requires an open approach grounded on broad interoperability to centralize critical data and routine operations. Uppsala University Hospital selected Proscia for its novel ability to empower the modern laboratory with its enterprise-class platform that addresses current and future requirements, strategically improves decision-making, drives new discoveries, and accelerates medical breakthroughs.

Proscia’s technology will drive Uppsala’s modernization efforts and its goal of becoming completely digitized. The technology will support the region in achieving widespread, seamless integration with leading scanners, laboratory information systems, and image analysis applications. Proscia’s Concentriq will equip the clinical pathology lab at University Hospital with streamlined and intuitive workflows that ensure secure, remote access to cases and images.

Daytona Unveils Agent-Agnostic Infrastructure for Sandboxing AI Coding Assistants

Oct 31, 2024

Verax AI Raises $7.6 million in Seed Funding Led by TQ Ventures

Oct 31, 2024

Quantiphi Expands Strategic Partnership with Google Cloud to Drive Enterprise-wide AI Adoption, Customer Value

Oct 31, 2024

Prev Next 1 of 40,344

“Uppsala University Hospital is propelled by its vision to become the leading university hospital creating the most value for its patients,” said professor emerita, senior consultant in neuropathology, Irina Alafuzoff, Section Manager of Clinical Pathology, part of the laboratory medicine division at Uppsala University Hospital. “As we strive to advance our region to a digitized future, our working group including several pathologists, biomedical analysts, and representatives with IT expertise, evaluated multiple enterprise solutions and selected Proscia for its highly nimble and knowledgeable approach to computational pathology. We are confident that Concentriq’s scalable and open platform will drive us to the forefront of innovation as we work to empower the future of our laboratories.”

Proscia’s Concentriq digital pathology platform is a robust, end-to-end solution for connecting distributed teams, data, and applications across the global enterprise. The flagship software is used by leading laboratories and health systems, as well as 10 of the top 20 pharmaceutical companies. With Concentriq, laboratories can tap into the interoperability and scalability required to achieve streamlined, reliable operations for pathologists and enhanced outcomes for patients.

“We are thrilled about the opportunity to invest in the Nordic region’s digitization efforts and honored to have been selected as Uppsala’s solution to achieve full digitization by 2024 and elevate the region as a center of excellence,” said David West, CEO, Proscia. “We look forward to helping Uppsala shift its pathology standard of care to a data-driven discipline and optimize their laboratory operations to drive rapid innovation within the field of pathology.”

[To share your insights with us, please write to sghosh@martechseries.com]